Javascript must be enabled to continue!
O-277 Exploring the relationship between the vaginal microbiota and vaginal symptoms
View through CrossRef
Abstract
Study question
What is the relationship between self-reported vaginal symptoms and the composition of the vaginal microbiome?
Summary answer
Our study reveals a complex and multifactorial relationship between vaginal symptoms and the composition of the vaginal microbiome.
What is known already
Vaginal dysbiosis (VD) is a microbial condition characterized by the absence of beneficial lactobacilli and the presence of pathogenic bacteria in the vagina. VD is associated with elevated risks of sexually transmitted infections, preterm birth, pregnancy loss, infertility, and suboptimal outcomes in in vitro fertilization. Clinical manifestations often include increased vaginal discharge and malodour, although it’s noteworthy that a substantial proportion of women with VD remain asymptomatic, which makes diagnosing these women challenging.
Study design, size, duration
Our study was conducted as part of a Double-Blinded Randomized Controlled Trial (RCT) evaluating Vaginal Microbiota Transplantation (VMT) as a novel approach for treating vaginal dysbiosis without antibiotics. This study included 263 women aged 18-40 years.
Participants/materials, setting, methods
We employed shotgun metagenomic sequencing to analyse the vaginal microbiome on cycle day 10+/-2 days. Moreover, we collected data on vaginal symptoms, hormonal contraceptive use, and sexual behaviour.
Main results and the role of chance
Among the 263 participants, 65% exhibited eubiotic microbiomes, 23% had dysbiotic microbiomes, and 12% had intermediate microbiomes. Vaginal symptoms were reported by 33%, while 63% remained symptom-free. In terms of dominance, L. crispatus dominated in 40% of samples, followed by L. iners (30%) and G. vaginalis (9.1%). In symptomatic women, L. iners (22%) and L. crispatus (21%) were common taxa, while asymptomatic women showed higher prevalence of these taxa: L. crispatus (50%) and L. iners (34%). Symptoms analysis showed two significant clusters dominated by L. crispatus or L. iners, along with smaller dysbiotic clusters led by G. vaginalis and F. vaginae. Dysbiotic samples exhibited higher rates of increased discharge and malodor, while stinging and itching were more prevalent in eubiotic samples. Positive associations were noted between specific microbial taxa and distinct symptoms. Exploring external factors, contraceptive use revealed weak associations with microbial changes. Sexual behavior patterns also influenced microbial composition, notably in women with varying numbers of male sexual partners within the last 3 months. These findings provide valuable insights into the intricate interactions between vaginal microbiota, symptoms, and external factors, shedding light on the complex landscape of vaginal dysbiosis.
Limitations, reasons for caution
Our study is limited by the cross-sectional design, and causality cannot be inferred. Self-reporting of symptoms may introduce bias. Additionally, our findings may not be generalizable to all populations sin the majority of the women in our cohort are younger and likely to have higher education
Wider implications of the findings
Our findings highlight the complexity of VD symptomatology and underscore the need for further research into the relationship between vaginal symptoms, microbiota and clinical outcomes.
Trial registration number
NCT04855006
Oxford University Press (OUP)
Title: O-277 Exploring the relationship between the vaginal microbiota and vaginal symptoms
Description:
Abstract
Study question
What is the relationship between self-reported vaginal symptoms and the composition of the vaginal microbiome?
Summary answer
Our study reveals a complex and multifactorial relationship between vaginal symptoms and the composition of the vaginal microbiome.
What is known already
Vaginal dysbiosis (VD) is a microbial condition characterized by the absence of beneficial lactobacilli and the presence of pathogenic bacteria in the vagina.
VD is associated with elevated risks of sexually transmitted infections, preterm birth, pregnancy loss, infertility, and suboptimal outcomes in in vitro fertilization.
Clinical manifestations often include increased vaginal discharge and malodour, although it’s noteworthy that a substantial proportion of women with VD remain asymptomatic, which makes diagnosing these women challenging.
Study design, size, duration
Our study was conducted as part of a Double-Blinded Randomized Controlled Trial (RCT) evaluating Vaginal Microbiota Transplantation (VMT) as a novel approach for treating vaginal dysbiosis without antibiotics.
This study included 263 women aged 18-40 years.
Participants/materials, setting, methods
We employed shotgun metagenomic sequencing to analyse the vaginal microbiome on cycle day 10+/-2 days.
Moreover, we collected data on vaginal symptoms, hormonal contraceptive use, and sexual behaviour.
Main results and the role of chance
Among the 263 participants, 65% exhibited eubiotic microbiomes, 23% had dysbiotic microbiomes, and 12% had intermediate microbiomes.
Vaginal symptoms were reported by 33%, while 63% remained symptom-free.
In terms of dominance, L.
crispatus dominated in 40% of samples, followed by L.
iners (30%) and G.
vaginalis (9.
1%).
In symptomatic women, L.
iners (22%) and L.
crispatus (21%) were common taxa, while asymptomatic women showed higher prevalence of these taxa: L.
crispatus (50%) and L.
iners (34%).
Symptoms analysis showed two significant clusters dominated by L.
crispatus or L.
iners, along with smaller dysbiotic clusters led by G.
vaginalis and F.
vaginae.
Dysbiotic samples exhibited higher rates of increased discharge and malodor, while stinging and itching were more prevalent in eubiotic samples.
Positive associations were noted between specific microbial taxa and distinct symptoms.
Exploring external factors, contraceptive use revealed weak associations with microbial changes.
Sexual behavior patterns also influenced microbial composition, notably in women with varying numbers of male sexual partners within the last 3 months.
These findings provide valuable insights into the intricate interactions between vaginal microbiota, symptoms, and external factors, shedding light on the complex landscape of vaginal dysbiosis.
Limitations, reasons for caution
Our study is limited by the cross-sectional design, and causality cannot be inferred.
Self-reporting of symptoms may introduce bias.
Additionally, our findings may not be generalizable to all populations sin the majority of the women in our cohort are younger and likely to have higher education
Wider implications of the findings
Our findings highlight the complexity of VD symptomatology and underscore the need for further research into the relationship between vaginal symptoms, microbiota and clinical outcomes.
Trial registration number
NCT04855006.
Related Results
Vaginal microbiota and preterm birth
Vaginal microbiota and preterm birth
Vaginal microbiota composition is associated with spontaneous preterm birth (sPTB), depending on ethnicity. Host-microbiota interactions are thought to play an important underlying...
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The work presented is a comprehensive review of the role of the human microbiota in the context of the COVID-19 pandemic. A diverse microbial community heavily colonizes the human ...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Detection of predefined bacterial species in the Vaginal Microbiota in SARS-COV-2-Positive Patients
Detection of predefined bacterial species in the Vaginal Microbiota in SARS-COV-2-Positive Patients
Abstract
Whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be found in the vagina of infected women remains unclear; moreover, the impact of t...
Abstract P6-12-13: Developing a non-hormonal treatment for vaginal dryness for breast cancer survivors: A pilot study of a therapeutic ultrasound device
Abstract P6-12-13: Developing a non-hormonal treatment for vaginal dryness for breast cancer survivors: A pilot study of a therapeutic ultrasound device
Abstract
Objectives: Breast cancer survivors need a non-hormonal treatment for vaginal dryness, as estrogen replacement therapy is often contraindicated or undesired...
Imbalance of vaginal microbiota and immunity: two main accomplices of cervical cancer
Imbalance of vaginal microbiota and immunity: two main accomplices of cervical cancer
Abstract
Objective: To explore the relationship between female vaginal microbiota and immune factors and its correlation with cervical cancer.
Methods: Here, we assessed th...
Causal relationship between gut microbiota and malignant lymphoma:a two-way two-sample Mendelian randomization study
Causal relationship between gut microbiota and malignant lymphoma:a two-way two-sample Mendelian randomization study
Abstract
Background
The significance of gut microbiota in human health is gaining attention, leading to a rise in observational and clinical studies focused on understandi...
P-114. Efficacy of Vaginal-Spraying Bacillus Spore Probiotics in Supportive Treatment of Sexual Transmission Infections: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
P-114. Efficacy of Vaginal-Spraying Bacillus Spore Probiotics in Supportive Treatment of Sexual Transmission Infections: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Abstract
Background
Sexually Transmitted Infections (STIs) are common gynecological infections worldwide. While antibiotics drug...

